» Articles » PMID: 23150828

The Role of Large-format Histopathology in Assessing Subgross Morphological Prognostic Parameters: a Single Institution Report of 1000 Consecutive Breast Cancer Cases

Overview
Publisher Wiley
Date 2012 Nov 15
PMID 23150828
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Breast cancer subgross morphological parameters (disease extent, lesion distribution, and tumor size) provide significant prognostic information and guide therapeutic decisions. Modern multimodality radiological imaging can determine these parameters with increasing accuracy in most patients. Large-format histopathology preserves the spatial relationship of the tumor components and their relationship to the resection margins and has clear advantages over traditional routine pathology techniques. We report a series of 1000 consecutive breast cancer cases worked up with large-format histology with detailed radiological-pathological correlation. We confirmed that breast carcinomas often exhibit complex subgross morphology in both early and advanced stages. Half of the cases were extensive tumors and occupied a tissue space ≥40 mm in its largest dimension. Because both in situ and invasive tumor components may exhibit unifocal, multifocal, and diffuse lesion distribution, 17 different breast cancer growth patterns can be observed. Combining in situ and invasive tumor components, most cases fall into three aggregate growth patterns: unifocal (36%), multifocal (35%), and diffuse (28%). Large-format histology categories of tumor size and disease extent were concordant with radiological measurements in approximately 80% of the cases. Noncalcified, low-grade in situ foci, and invasive tumor foci <5 mm were the most frequent causes of discrepant findings.

Citing Articles

The unifying concepts of the sick lobe hypothesis, field cancerisation and breast conservation treatment for multiple ipsilateral breast cancers: a narrative review.

Tan M, Sitoh Y Gland Surg. 2023; 12(4):535-547.

PMID: 37200923 PMC: 10186170. DOI: 10.21037/gs-22-609.


Contrast-enhanced mammography (CEM) versus MRI for breast cancer staging: detection of additional malignant lesions not seen on conventional imaging.

Taylor D, Burrows S, Saunders C, Parizel P, Ives A Eur Radiol Exp. 2023; 7(1):8.

PMID: 36781808 PMC: 9925630. DOI: 10.1186/s41747-022-00318-5.


Pathological Diagnosis, Work-Up and Reporting of Breast Cancer 1st Central-Eastern European Professional Consensus Statement on Breast Cancer.

Cserni G, Francz M, Jaray B, Kalman E, Kovacs I, Krenacs T Pathol Oncol Res. 2022; 28:1610373.

PMID: 35845921 PMC: 9284216. DOI: 10.3389/pore.2022.1610373.


Progress on deep learning in digital pathology of breast cancer: a narrative review.

Zhu J, Liu M, Li X Gland Surg. 2022; 11(4):751-766.

PMID: 35531111 PMC: 9068546. DOI: 10.21037/gs-22-11.


Development and External Validation of a Simple-To-Use Dynamic Nomogram for Predicting Breast Malignancy Based on Ultrasound Morphometric Features: A Retrospective Multicenter Study.

Zhang Q, Zhang Q, Liu T, Bao T, Li Q, Yang Y Front Oncol. 2022; 12:868164.

PMID: 35463357 PMC: 9021381. DOI: 10.3389/fonc.2022.868164.


References
1.
Tot T, Pekar G, Hofmeyer S, Sollie T, Gere M, Tarjan M . The distribution of lesions in 1-14-mm invasive breast carcinomas and its relation to metastatic potential. Virchows Arch. 2009; 455(2):109-15. DOI: 10.1007/s00428-009-0808-9. View

2.
Katz A, Strom E, Buchholz T, Theriault R, Singletary S, McNeese M . The influence of pathologic tumor characteristics on locoregional recurrence rates following mastectomy. Int J Radiat Oncol Biol Phys. 2001; 50(3):735-42. DOI: 10.1016/s0360-3016(01)01500-0. View

3.
Tot T, Pekar G . Multifocality in "basal-like" breast carcinomas and its influence on lymph node status. Ann Surg Oncol. 2010; 18(6):1671-7. DOI: 10.1245/s10434-010-1480-7. View

4.
Andea A, Wallis T, Newman L, Bouwman D, Dey J, Visscher D . Pathologic analysis of tumor size and lymph node status in multifocal/multicentric breast carcinoma. Cancer. 2002; 94(5):1383-90. DOI: 10.1002/cncr.10331. View

5.
Cserni G . Commentary on in-transit lymph node metastases in breast cancer: a possible source of local recurrence after Sentinel Node procedure. J Clin Pathol. 2008; 61(12):1233-5. DOI: 10.1136/jcp.2008.060848. View